Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Pati… (NCT06498310) | Clinical Trial Compass
RecruitingNot Applicable
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
France100 participantsStarted 2023-11-08
Plain-language summary
Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patient ≥18 years old
* Heart transplant
* Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022
* Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria (20):
* Invasive aspergillosis
* Mucormycosis
* Fusarium wilt
* Scedosporiosis
* Other filamentous fungus infection
* Subject who has not expressed, after information, his opposition to the reuse of his data for the purposes of this research.
Exclusion Criteria:
* Patient having expressed his opposition to participating in the study
* Patient not having a liver transplant
* Subject under guardianship, curatorship or safeguard of justice.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
To identify the incidence, risk factors and prognostic factors associated with invasive fungal infections caused by filamentous fungi in heart transplant patients.